Researchers are exploring the effects of stopping or transitioning from GLP-1 drugs, which may lead to a loss of cardiovascular benefits and weight regain. Some studies suggest that stopping and restarting certain GLP-1s could make the drug less effective for weight loss. Scientists may have made discoveries that could address the issue of weight regain after stopping GLP-1 treatment, but the outcomes and implications of transitioning from these drugs are not yet fully clear.